# TRIESENCE

NDC: 0078-0897
Generic name: triamcinolone acetonide
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION
Routes: OPHTHALMIC
Marketing started: 20241001

FDA application: NDA022048

## Active ingredients

- TRIAMCINOLONE ACETONIDE: 40 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0897"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0897
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22692d92-1359-9252-e063-6394a90ab669